Skip to main content

Advertisement

SpringerLink
Log in

Different clinicopathological features between patients who developed early and late recurrence following surgery for renal cell carcinoma

  • Original Article
  • Published:
International Journal of Clinical Oncology Aims and scope Submit manuscript

Abstract

Background

To evaluate the clinicopathological features and identify predictive factors in patients with early and late recurrence following initial surgery for localized renal cell carcinoma.

Methods

From April 1988 to January 2013, 486 patients without metastases at the initial diagnosis underwent either radical nephrectomy or partial nephrectomy and were followed up thereafter. Patients were divided into 3 groups; no recurrence, early recurrence (recurrence within 5 years), and late recurrence (recurrence after 5 years). Cancer-specific survival after recurrence was analyzed by using the Kaplan–Meier method. Multivariate logistic regression analysis was applied to define clinical and pathological factors correlated to early and late recurrence following surgery.

Results

Seventy-seven (15.8 %) and 18 (3.7 %) patients developed early and late recurrence, respectively. In multivariate logistic regression analysis, positive symptoms at diagnosis, ≥pT2, positive lymphovascular invasion, and grade 3 were independent predictive factors for early recurrence. Age at surgery and ≥pT2 were significantly correlated to late recurrence. The 5-year cancer-specific survival rate after recurrence was 72.4 and 52.9 % in the late and the early recurrence groups, respectively (P = 0.044).

Conclusions

The risk factors for clinical recurrence differed according to the time that had elapsed between initial surgery and the first metastasis in patients with localized renal cell carcinoma. Our study showed age at initial surgery and the pT stage were independent predictive factors for late recurrence. Further investigation of a larger number of patients is required to predict which patients may develop recurrence in the future and to choose appropriate treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Ljungberg B, Cowan NC, Hanbury DC et al (2010) EAU guidelines on renal cell carcinoma: the 2010 update. Eur Urol 58:398–406

    Article  PubMed  Google Scholar 

  2. Hollingsworth JM, Miller DC, Daignault S et al (2007) Five-year survival after surgical treatment for kidney cancer: a population-based competing risk analysis. Cancer 109:1763–1768

    Article  PubMed  Google Scholar 

  3. Nguyen MM, Gill IS, Ellison LM (2006) The evolving presentation of renal carcinoma in the United States: trends from the surveillance, epidemiology, and end results program. J Urol 176:2397–2400

    Article  PubMed  Google Scholar 

  4. Kim SP, Weight CJ, Leibovich BC et al (2011) Outcomes and clinicopathologic variables associated with late recurrence after nephrectomy for localized renal cell carcinoma. Urology 78:1101–1106

    Article  PubMed  Google Scholar 

  5. Ljungberg B, Alamdari FI, Rasmuson T et al (1999) Follow-up guidelines for nonmetastatic renal cell carcinoma based on the occurrence of metastases after radical nephrectomy. BJU Int 84:405–411

    Article  CAS  PubMed  Google Scholar 

  6. Nakano E, Fujioka H, Matsuda M et al (1984) Late recurrence of renal cell carcinoma after nephrectomy. Eur Urol 10:347–349

    CAS  PubMed  Google Scholar 

  7. Gelb AB (1997) Renal cell carcinoma: current prognostic factors. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer 80:981–986

    Article  CAS  PubMed  Google Scholar 

  8. Thrasher JB, Paulson DF (1993) Prognostic factors in renal cancer. Urol Clin North Am 20:247–262

    CAS  PubMed  Google Scholar 

  9. Edge SB, Compton CC (2010) The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 17:1471–1474

    Article  PubMed  Google Scholar 

  10. Nguyen DX, Bos PD, Massague J (2009) Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer 9:274–284

    Article  CAS  PubMed  Google Scholar 

  11. Naumov GN, Folkman J, Straume O (2009) Tumor dormancy due to failure of angiogenesis: role of the microenvironment. Clin Exp Metastasis 26:51–60

    Article  PubMed  Google Scholar 

  12. Husemann Y, Geigl JB, Schubert F et al (2008) Systemic spread is an early step in breast cancer. Cancer Cell 13:58–68

    Article  PubMed  Google Scholar 

  13. Braun S, Pantel K, Muller P et al (2000) Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer. N Engl J Med 342:525–533

    Article  CAS  PubMed  Google Scholar 

  14. Brookman-May S, May M, Shariat SF et al (2013) Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN project). Eur Urol 64:472–477

    Article  PubMed  Google Scholar 

  15. Park YH, Baik KD, Lee YJ et al (2012) Late recurrence of renal cell carcinoma >5 years after surgery: clinicopathological characteristics and prognosis. BJU Int 110:553–558

    Article  Google Scholar 

  16. Adamy A, Chong KT, Chade D et al (2011) Clinical characteristics and outcomes of patients with recurrence 5 years after nephrectomy for localized renal cell carcinoma. J Urol 185:433–438

    Article  PubMed  Google Scholar 

  17. Uchida K, Miyao N, Masumori N et al (2002) Recurrence of renal cell carcinoma more than 5 years after nephrectomy. Int J Urol 9:19–23

    Article  PubMed  Google Scholar 

  18. Kyoda Y, Kobayashi K, Hirobe M et al (2014) Evaluation of long-term outcome for patients with renal cell carcinoma after surgery: analysis of cancer deaths occurring more than 10 years after initial treatment. Int J Clin Oncol 19:146–151

    Article  PubMed  Google Scholar 

  19. Kavolius JP, Mastorakos DP, Pavlovich C et al (1998) Resection of metastatic renal cell carcinoma. J Clin Oncol 16:2261–2266

    CAS  PubMed  Google Scholar 

  20. Maldazys JD, deKernion JB (1986) Prognostic factors in metastatic renal carcinoma. J Urol 136:376–379

    CAS  PubMed  Google Scholar 

  21. Kroeger N, Choueiri TK, Lee JL et al (2014) Survival outcome and treatment response of patients with late relapse from renal cell carcinoma in the era of targeted therapy. Eur Urol 65:1086–1092

    Article  PubMed  Google Scholar 

  22. Motzer RJ, Hutson TE, Tomczak P et al (2007) Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N Engl J Med 356:115–124

    Article  CAS  PubMed  Google Scholar 

  23. Escudier B, Eisen T, Stadler WM et al (2007) Sorafenib in advanced clear-cell renal-cell carcinoma. N Engl J Med 356:125–134

    Article  CAS  PubMed  Google Scholar 

  24. Rini BI, Escudier B, Tomczak P et al (2011) Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial. Lancet 378:1931–1939

    Article  CAS  PubMed  Google Scholar 

  25. Hudes G, Carducci M, Tomczak P et al (2007) Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. N Engl J Med 356:2271–2281

    Article  CAS  PubMed  Google Scholar 

  26. Motzer RJ, Escudier B, Oudard S et al (2008) Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial. Lancet 372:449–456

    Article  CAS  PubMed  Google Scholar 

  27. Levy DA, Slaton JW, Swanson DA et al (1998) Stage specific guidelines for surveillance after radical nephrectomy for local renal cell carcinoma. J Urol 159:1163–1167

    Article  CAS  PubMed  Google Scholar 

  28. Fidler IJ (2003) The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited. Nat Rev Cancer 3:453–458

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

There is no especial acknowledgement.

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Urology, Toranomon Hospital, 2-2-2 Toranomon, Minato-Ku, Tokyo, 105-8470, Japan

    Yoichi Fujii, Masaomi Ikeda, Kazuhiro Kurosawa, Mariko Tabata, Takayuki Kamigaito, Chihiro Hosoda & Toshikazu Okaneya

Authors
  1. Yoichi Fujii
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Masaomi Ikeda
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kazuhiro Kurosawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mariko Tabata
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Takayuki Kamigaito
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Chihiro Hosoda
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Toshikazu Okaneya
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Masaomi Ikeda.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fujii, Y., Ikeda, M., Kurosawa, K. et al. Different clinicopathological features between patients who developed early and late recurrence following surgery for renal cell carcinoma. Int J Clin Oncol 20, 802–807 (2015). https://doi.org/10.1007/s10147-014-0775-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10147-014-0775-2

Keywords

Search

Navigation